Specificity: This antibody binds lipoarabinomannon and recognizes the common terminal branched arafcontaining arrangement.
Host: Human
Application: ELISA, WB, FC, IF
Summary
Specifications
Antibody Isotype
IgG
Clone
CS-35
Species Reactivity
M. leprae; M. tuberculosis; M. bovis
Immunogen
The original antibody was generated against LAM from Mycobacterium leprae.
Conjugate
Unconjugated
Applications
Application Notes
Suitable for use in ELISA, WB, FC, IF. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
General Notes
The Hi-Puri™ Human Anti-LAM Monoclonal Antibody (clone CS-35, product code DMAB-CPDB152)is a monoclonal antibody specifically directed against LAM. This product is validated for use in ELISA, WB, FC, IF. This antibody binds lipoarabinomannon and recognizes the common terminal branched arafcontaining arrangement. DMAB-CPDB152 is purified by affinity purification and supplied as a liquid formulation in PBS. It is available in multiple sizes, including 100 μg, 200 μg, 500 μg, and 1 mg. For long-term storage, the product should be stored at −20°C and repeated freeze–thaw cycles should be avoided. The product is shipped on dry ice. This product is intended for research use only and is not intended for diagnostic use.
Target
Alternative Names
Lipoarabinomannan; LAM
Citations
Publication ()
Have you cited DMAB-CPDB152 in a publication? Let us know and earn a reward for your research.
My Review for Hi-Puri™ Human Anti-LAM Monoclonal Antibody, clone CS-35
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
